YM BioSciences Inc. (YMI)

[imshirazy]

4.5 - 5 is more realistic imho. I'm aiming for a target of 4 and I'll be happy. I'll probably pull out half of it after it hits 4, this of course depends what makes it get to 4.
If 4 consists of FDA approval; PIII; partnership, then I get out. Those are the main 3 things right now in YM's pipeline to make it bounce(amongst other smaller things). Undoubtedly there will be more things in the future such as new drugs, marketing, etc. But those will be more so years than <1yr. I see plenty of other company opportunities that can bounce sooner, which is why I do love YMI, but I'm in stocks to make money like most of you.
If it gets to 4 before any of those three things hit, then all the better and I'll stay in longer. Looks like so far the 5 million share buy wasn't an institution, then again it may be too early for a SEC filing? But I see no new filings, last one was late March.
Realistically as well, Nimo is not a well marketed drug, but their JAK inhibitor/CYT is. Remember too that even after FDA, these things can take 3-4 years to get moving. YM is still an early stage company, which is doing pretty well regardless. I'm fairly certain that regardless of your short/medium/long position, anyone should do fine in YM.